Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation

European Journal of Heart Failure

Volumn 10, Issue 6, 2008, Pages 573-580

  Dini, Frank Lloyd ^a   Fontanive, Paolo ^a   Panicucci, Erica ^a,b   Andreini, Diana ^a   Chella, Piersilvio ^a   De Tommasi, Salvatore Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Dilated cardiomyopathy; Functional mitral regurgitation; Natriuretic peptides; Prognosis; Right ventricular function

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TRICUSPID VALVE;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 44649131837     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.04.003     Document Type: Article

References (39)

1. Blondheim D.S., Jacobs L.E., Kotler M.N., Costacurta G.A., and Parry W.R. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 122 (1991) 763-771
2. Grigioni F., Enriquez-Sarano M., Zehr K.J., Bailey K.R., and Tajik A.J. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
3. Trichon B.H., Felker G.M., Shaw L.K., Cabell C.H., and O'Connor C.M. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003) 538-543
4. Pu M. The frequency, impact, and management of mitral regurgitation in patients with heart failure. Curr Cardiol Rep 8 (2006) 226-231
5. Patel J.B., Borgeson D.D., Barnes M.E., Rihal C.S., Daly R.C., and Redfield M.M. Mitral regurgitation in patients with advanced heart failure. J Card Fail 10 (2004) 285-291
6. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 (2005) 875-883
7. Enriquez-Sarano M., Rossi A., Seward J.B., Bailey K.R., and Tajik A.J. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 29 (1997) 153-159
8. Mariano-Goulart D., Eberlé M.C., Boudousq V., et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. Eur J Heart Fail 5 (2003) 481-488
9. Redington A.N. Right ventricular function. Cardiol Clin 20 (2002) 341-349
10. Lang R.M., Bierig M., and Deveraux R.B. Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006) 79-108
11. Zornoff L.A.M., Skali H., Pfeffer M.A., et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 39 (2002) 1450-1455
12. Ghio S., Recusani F., Klerski C., et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 85 (2000) 837-842
13. Hall S., Brickner M., Willet D., Irani W.N., Afridi I., and Grayburn P.A. Assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Circulation 95 (1997) 636-642
14. Appleton C.P., Hatle L.K., and Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12 (1988) 426-440
15. Temporelli P.L., Scapellato F., Corrà U., Eleuteri E., Imparato A., and Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 83 (1999) 724-727
16. Vogel M., Schmidt M.R., Kristiansen S., et al. Myocardial acceleration during isovolumic contraction, a novel index to assess right ventricular contractility: validation in an animal model. Circulation 105 (2002) 1693-1699
17. Quinones M.A., Otto C.M., Stoddard M., Waggoner A., and Zoghbi W.A. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification Task Force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15 (2002) 167-184
18. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 Suppl VI (1993) 5-15
19. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiographic and tissue Doppler in the estimation of left ventricular filling pressures. Circulation 102 (2000) 1788-1794
20. Bruch C., Rothenburger M., Gotzmann M., et al. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr 19 (2006) 522-528
21. Grayburn P.A., Appleton C.P., DeMaria A.N., et al. Best trial echocardiographic substudy investigators: echocardiographic predictors of morbidity and mortality in patients with advanced heart failure. J Am Coll Cardiol 45 (2005) 1064-1071
22. Polak J.F., Holman B.L., Wynne J., and Colucci W.S. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 2 (1983) 217-224
23. Mendes L.A., Dec G.W., Picard M.H., Palacios I.F., Newell J., and Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128 (1994) 301-307
24. Juilliere Y., Barbier G., Feldmann L., Grentzinger A., Danchin N., and Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 18 (1997) 276-280
25. De Groote P., Millaire A., Foucher-Hossein C., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 32 (1998) 948-954
26. Hochreiter C., Niles N., Devereux R.B., Klingfield P., and Borer J.S. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 73 (1986) 900-912
27. Karatasakis G.T., Karagouinis L.A., Kalyvas P.A., et al. Prognostic significance of echocardiographycally estimated right ventricular shortening. Am J Cardiol 82 (1998) 329-334
28. Meluzìn J., Spiranova L., Dusek L., Toman J., Hude P., and Krejci J. Prognostic importance of right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr 4 (2003) 262-271
29. Kjaergaard J., Akkan D., Iversen K.K., Kober L., Torp-Pedersen C., and Hassager C. Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail 9 (2007) 610-616
30. Thomas L., Foster E., and Schiller N.B. Peak mitral inflow velocity predicts mitral regurgitation severity. J Am Coll Cardiol 31 (1998) 174-179
31. Bruch C., Klem I., Breithardt G., Wichter T., and Gradaus R. Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol 100 (2007) 860-865
32. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
33. Troughton R.W., Prior D.L., Pereira J.J., et al. Plasma B-Type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43 (2004) 416-422
34. Tulevski I., Groenink M., van der Wall E.E., et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 86 (2001) 27-30
35. Lopez-Candales A., Rajagopalan N., Saxena N., Gulyasy B., Edelman K., and Bazaz R. Right ventricular systolic function is not the sole determinant of tricuspid annular motion. Am J Cardiol 98 (2006) 973-977
36. Borer J.S., Hochreiter C., and Rosen S. Right ventricular dysfunction in severe nonischemic mitral insufficiency. Eur Heart J 12 Suppl B (1991) 22-25
37. Bleeker G.B., Schalij M.J., Nihoyannopoulos P., et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol 46 (2005) 2264-2269
38. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50 (2004) 33-50
39. Parthenakis F.I., Patrianakos A.P., Skalidis E.I., et al. Atrial fibrillation is associated with increased neurohormonal activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 118 (2007) 206-214